So, to me, if you have a bad actor that has acted poorly or badly in the past, mitigation versus removing, I am not sure what the difference would be or why we would go back to dealing with certain firms, knowing the threats that they present to our country.
Correa questions the rationale for engaging with companies that have a history of poor conduct.
Share & report
More from J. Correa
Antibody-dependent enhancements, or ADE, from the vaccines could cause millions of deaths.
this is very disturbing. That statement is an understatement as to how I'm feeling right now.
This hearing is about going after responsible fiduciary investing and shareholders who are essentially exercising their legal rights under the law.
I don't agree with that law because under this existing law, most of our ancestors probably wouldn't qualify to come to this country.
Other voices in this conversation
